| Mitch K. Goldenberg |
Mitch K. Goldenberg is currently the VP-Information Technology & Infrastructure at Concert Pharmaceuticals, Inc. He completed his undergraduate degree at Rensselaer Polytechnic Institute and his graduate degree at Harvard Extension School. |
| Virginia Braman |
Virginia Braman is currently the Vice President of Clinical Development at Concert Pharmaceuticals, Inc. Prior to her current position, no other job history is provided. She obtained an undergraduate degree from Northeastern University. |
| Marc A. Becker |
Marc A. Becker is currently the Director at Food For Free and the Chief Financial & Accounting Officer at Concert Pharmaceuticals, Inc. Previously, he worked as the Vice President-Finance at Genzyme Corp. from 2001 to 2011, and as the CFO, Secretary, Treasurer & Senior VP at rEVO Biologics, Inc. from 2012 to 2016. He also served as the Chief Financial Officer & Senior Vice President at CRISPR Therapeutics AG from 2016 to 2017. Mr. Becker has an MBA from Babson College and an undergraduate degree from the University of Massachusetts. |
| Jeffrey A. Munsie |
Jeffrey A. Munsie is currently the Chief Legal Officer at Concert Pharmaceuticals, Inc. Prior to his current position, he served as the SVP, Head-Operations & General Counsel at Merrimack Pharmaceuticals, Inc. from 2017 to 2019. Before that, he worked as Counsel at Wilmer Cutler Pickering Hale & Dorr LLP from 2002 to 2011. Mr. Munsie completed his undergraduate studies at Dartmouth College and obtained his graduate degree from Harvard Law School. |
| Nancy Stuart |
Nancy Stuart is currently the Director at the Young Men's Christian Association of Greater Boston, Inc. She is also an Independent Director at KalVista Pharmaceuticals, Inc. since 2021 and the Chief Operating Officer at Concert Pharmaceuticals, Inc. since 2007. In her former positions, Ms. Stuart worked as a Principal at Amgen, Inc., Vertex Pharmaceuticals, Inc., Genzyme Corp., Faraday Pharmaceuticals, Inc. (Washington), and Kinetix Pharmaceuticals, Inc.Ms. Stuart completed her undergraduate degree at the University of Michigan in 1980. She later obtained an MBA from Simmons School of Management in 1987. |
| James V. Cassella |
James V. Cassella is an Independent Director at Trevi Therapeutics, Inc. and the Chief Development Officer & Senior Vice President at Concert Pharmaceuticals, Inc. He was previously the Senior VP-Clinical Research & Development at Neurogen Corp. from 1989 to 2004 and the CSO, Executive VP-Research & Development at Alexza Pharmaceuticals, Inc. from 2013 to 2015. He also worked as an Assistant Professor at Oberlin College. Cassella holds a doctorate degree from Dartmouth College and an undergraduate degree from the University of New Haven. |
| Roger D. Tung |
Roger D. Tung is the founder of Concert Pharmaceuticals, Inc. which was founded in 2006, where he holds the titles of President, Chief Executive Officer & Director. He is currently an Advisor at Longwood Fund Management LLC. Dr. Tung's former positions include being an Independent Director at Flex Pharma, Inc. from 2017 to 2019, and Vice President-Drug Discovery at Vertex Pharmaceuticals, Inc. from 1989 to 2005. He also held the title of Principal at Organon Pharma (UK) Ltd. Dr. Tung received his undergraduate degree from The Reed Institute and his doctorate from the University of Wisconsin. |
| Jesper Høiland |
Jesper Høiland is on the board of Concert Pharmaceuticals, Inc. and Senior Vice President of Novo Nordisk North America, Inc.
In his past career Mr. Høiland occupied the position of President, Chief Executive Officer& Director at Radius Health, Inc., Senior Vice President-International Operations at Novo Nordisk A President at Novo Nordisk, Inc. and General Manager at Novo Nordisk Pharmaceuticals Pty Ltd. (both are subsidiaries of Novo Nordisk A), Global Chief Commercial Officer & Senior VP at Ascendis Pharma An and Management Consultant at Liseberg AB.
He received a graduate degree from Copenhagen Business School. |
